Annals of Internal Medicine · Nov 3, 2026

In T2D, combined SGLT2i + GLP-1 RA vs. either alone does not reduce MACE or renal outcomes

By Atri-Schuller A, Montori VM, ACP Journal Club Editorial Team at McMaster University

GIM/FP/GP: [Formula: see text] Endocrinology: [Formula: see text].

doi.org/10.7326/annals-26-04072-jcPubMed 42970805Interventions